What’s new in RSV immunizations for infants: the Canadian landscape
Moderated by the Centre for Vaccine Preventable Diseases’ Tiffany Fitzpatrick, experts Sarah Buchan and Jesse Papenburg will discuss the respiratory syncytial virus (RSV) immunization landscape in Canada and findings from the 2024-2025 inaugural universal RSV...
2024 Respiratory trends: Navigating the threat of RSV, influenza, and COVID-19
As we enter the new year, concerns are echoing from health officials about the growing triple threat: the combined surge of COVID-19, influenza, and respiratory syncytial virus (RSV). The US Centers for Disease Control and Prevention sounded the alarm with a notable...
What you need to know about the three fall vaccines, according to U of T experts
As cold and flu season approaches, Canadians are facing respiratory syncytial virus (RSV), an increase in COVID-19 activity, and influenza — but also have new options to protect their health. To learn more, we spoke with Shelly Bolotin, director of the Centre for Vaccine Preventable Diseases, Shaun Morris, a pediatric infectious disease physician at the Hospital for Sick Children, and Allison McGeer, an infectious disease specialist at Toronto’s Sinai Health.